podcast
details
.com
Print
Share
Look for any podcast host, guest or anyone
Search
Showing episodes and shows of
Michael Blaiss
Shows
allergytalk
Understanding the FDA Warning on Cetirizine/Levocetirizine
Welcome to a special episode of AllergyTalk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma & Immunology! On May 16, 2025, the FDA issued an alert regarding a rare but serious side effect of severe pruritus after discontinuing long-term use of cetirizine and levocetirizine. In this episode, we’ll discuss the background of this important announcement and what it means for our patients! We are joined by Michael S. Blaiss, MD, clinical professor of pediatrics at the Medical College of Georgia and past-president and former Executive Medical Di...
2025-06-09
27 min
CCO Medical Specialties Podcast
Conversations in Chronic Cough: An Allergist’s Perspective
Listen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough.PresenterMichael S. Blaiss, MDClinical Professor of PediatricsDivision of Allergy-ImmunologyMedical College of Georgia at Augusta UniversityAugusta, GeorgiaLink to full program: https://bit.ly/4kweynG
2025-05-28
16 min
The Itch: Allergies, Asthma, Eczema & Immunology
#109 - Tezepelumab & Nasal Polyps: Inside the WAYPOINT Phase III Trial
Have you wondered why having more drug options matters for chronic rhinosinusitis with nasal polyps? In the inaugural episode of our new series, The Itch Review, co-hosts Kortney and Dr. Payel Gupta, along with special guest Dr. Michael Blaiss, unpack the journal article "Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps," published in the New England Journal of Medicine on March 1, 2025. This article is about the Phase III WAYPOINT trial of tezepelumab. Already approved for severe asthma, this once-monthly biologic is now showing promise in chronic rhinosinusitis with nasal polyps (CRSwNP). Over 52 weeks, 408...
2025-04-24
27 min
The Itch: Allergies, Asthma, Eczema & Immunology
#109 - Tezepelumab & Nasal Polyps: Inside the WAYPOINT Phase III Trial
Have you wondered why having more drug options matters for chronic rhinosinusitis with nasal polyps? In the inaugural episode of our new series, The Itch Review, co-hosts Kortney and Dr. Payel Gupta, along with special guest Dr. Michael Blaiss, unpack the journal article "Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps," published in the New England Journal of Medicine on March 1, 2025. This article is about the Phase III WAYPOINT trial of tezepelumab. Already approved for severe asthma, this once-monthly biologic is now showing promise in chronic rhinosinusitis with nasal polyps (CRSwNP). Over 52 weeks, 408...
2025-04-24
27 min
The Itch: Allergies, Asthma, Eczema & Immunology
#102 - Comorbidities of Type 2 Inflammation
Why do conditions like asthma, nasal polyps, or eczema become more severe when they coexist? Kortney and Dr. Payel Gupta are joined by Dr. Michael Blaiss to explore the common thread linking multiple allergic and inflammatory diseases: Type 2 Inflammation. If you’ve ever wondered why certain conditions often appear together, this deep dive will help you connect the dots. Type 2 Inflammation is a hot topic in immunology because it’s the engine that drives many allergic and inflammatory diseases. It’s also the key to modern treatment strategies, including targeted biologic therapies. Dr. Blaiss explains how clinicians recogn...
2025-02-21
26 min
The Itch: Allergies, Asthma, Eczema & Immunology
#102 - Comorbidities of Type 2 Inflammation
Why do conditions like asthma, nasal polyps, or eczema become more severe when they coexist? Kortney and Dr. Payel Gupta are joined by Dr. Michael Blaiss to explore the common thread linking multiple allergic and inflammatory diseases: Type 2 Inflammation. If you’ve ever wondered why certain conditions often appear together, this deep dive will help you connect the dots. Type 2 Inflammation is a hot topic in immunology because it’s the engine that drives many allergic and inflammatory diseases. It’s also the key to modern treatment strategies, including targeted biologic therapies. Dr. Blaiss explains how clinicians recogn...
2025-02-21
26 min
Podcasts360
Management of Patients With Asthma: Critical Observations in Pulmonary Medicine, Ep. 6
In this episode, Albert Rizzo, MD, interviews Michael S. Blaiss, MD, to discuss allergic asthma and its comorbidities, including the definition, diagnosis, and management of patients with allergic asthma. They discussed the role of immunotherapy, inhaled steroids, biologics, and bronchial thermoplasty.
2022-07-07
27 min
MedEdTalks - Primary Care
Emerging Options for Refractory Chronic Cough
The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. Peter Dicpinigaitis discuss emerging therapeutic options for the management of patients with refractory chronic cough.
2019-12-10
07 min
MedEdTalks - Primary Care
Chronic Cough – A Typical Patient Journey
The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. John Russell and Dr. Michael Blaiss discuss the initial steps for the evaluation and management of patients presenting with chronic cough.
2019-12-10
10 min
MedEdTalks - Primary Care
Chronic Cough – Symptoms and Burden
The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. John Russell define chronic cough, discuss its symptoms, and review the associated physical and psychological burden of patients with this condition.
2019-12-10
08 min
Hot Topics in Allergy
Allergic Rhinitis and Sleep Disorders
Guest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.
2007-05-21
00 min
Sleep Medicine
Allergic Rhinitis and Sleep Disorders
Guest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.
2007-05-21
00 min
Allergy and Clinical Immunology
Allergic Rhinitis and Sleep Disorders
Guest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.
2007-05-21
00 min
Allergy and Clinical Immunology
Allergic Rhinitis and Sleep Disorders
Guest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.
2007-05-21
00 min